Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancer

BACKGROUND: This was a prospective single-centre, phase I study to document the maximum tolerated dose (MTD), dose-limiting toxicity (DLT), and the recommended phase II dose for future study of capecitabine in combination with radioembolization. METHODS: Patients with advanced unresectable liver-dom...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, S J, Konski, A A, Putnam, S, Ball, D S, Meyer, J E, Yu, J Q, Astsaturov, I, Marlow, C, Dickens, A, Cade, D N, Meropol, N J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102951/
https://www.ncbi.nlm.nih.gov/pubmed/24983373
http://dx.doi.org/10.1038/bjc.2014.344

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4102951/
https://www.ncbi.nlm.nih.gov/pubmed/24983373
http://dx.doi.org/10.1038/bjc.2014.344

Ejemplares similares